seed
Stage
1
Investors
About
ORIA Bioscience develops and supplies ready-to-use, highly pure isolated organelle preparations (e.g., lysosomes and mitochondria) using a patented microfluidic extraction and sorting workflow to accelerate drug discovery and improve assay reproducibility.
Explore Oria Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.